GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 107 filers reported holding GENMARK DIAGNOSTICS INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |